Stay Updated
Press Releases
PRESS RELEASE: A “Not-For-Profit” Vaccine From Johnson & Johnson?
Washington, D.C. — Johnson & Johnson is facing new questions from Patients For Affordable Drugs after our analysis found the drug company’s promise to offer a not-for-profit COVID-19 vaccine is more than a little misleading. As Johnson & Johnson (J&J) garnered positive press for its announcement, a closer look found that based on the company’s […]
Press Releases
Drug Corporations Didn't Invest in Vaccines Until a Global Pandemic
WASHINGTON, DC — In a new review, Patients For Affordable Drugs examined the drug industry’s historic disinterest in vaccines and treatments for global pandemics like COVID-19. P4AD found that while public health experts have warned of a pandemic for years, drug corporations were uninterested in developing new drugs until it was clear that vaccines and […]
Press Releases
Statement: Public-Private Partnership to Drive COVID-19 Research Overlooks Drug Prices
WASHINGTON, DC — In response to the new NIH-led public-private partnership to accelerate COVID-19 treatments and vaccines, David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs, issued the following statement: “We are glad the federal government is directing billions of taxpayer dollars to find treatments and vaccines for COVID-19. But since […]
Press Releases
Tracking COVID-19 Funds: How U.S. Taxpayers Are Investing in Vaccines and Treatments
WASHINGTON, D.C. — A new analysis by Patients For Affordable Drugs found that in one week in March, U.S. taxpayers gave more than $700 million to just three drug companies for research and development into COVID-19 vaccines and treatment. Today’s review — the first in a three-part series that will examine taxpayer investment into COVID-19 […]
Press Releases
Patients Call On Insulin Manufacturers To Respond To Covid-19 Pandemic And Lower List Prices
WASHINGTON, D.C. — With research showing that patients with diabetes have a higher mortality rate and are more likely to experience complications from COVID-19, Patients For Affordable Drugs and 63 people living with diabetes penned a letter to the Big 3 insulin manufacturers urging them to take action to lower the list prices of their […]
Press Releases
NEW VIDEO: Patient Advocate With $155k Drug Tab Raises Voice to Lower Drug Prices
WASHINGTON, D.C. — Patients For Affordable Drugs continues to elevate the voices of patients leading the fight to lower drug prices. This week, the organization will release its latest new video, “Savanna’s Story,” highlighting the $155,000 per year price the Texas college student faces. Watch the video here. Braun is a college student, Texan, and […]
Press Releases
BY THE NUMBERS: New Analysis Finds Over 500 Drug Price Hikes In First Week of January
WASHINGTON, DC — A new analysis by Patients For Affordable Drugs uncovered 524 drug price spikes in the first week of 2020, spotlighting widespread pharmaceutical industry price gouging that underscores the urgent need for Congress to address the issue. The non-profit group found that 72% of those price increases were on drugs with no generic […]
Press Releases
STATEMENT: Big Pharma Back To Business As Usual
WASHINGTON, DC — In response to the news that drugmakers raised the prices of more than 250 drugs on Jan. 1, Ben Wakana, Executive Director of Patients For Affordable Drugs, issued the following statement: “Big Pharma can’t break its addiction to price increases. Widespread price hikes to start the new year show why we can’t rely […]